Comments
Shares of Bal Pharma Ltd rose as much as 10.76 per cent to Rs 76.7, their highest since February 25, 2019.
The formulations manufacturing unit of the company at Uttarakhand received a good manufacturing practice (GMP) compliance certification according to European Union regulations, the company said on Thursday.
The approval allowed the plant to manufacture finished formulations for supplying to regulated markets of Europe, US, Japan and Australia among others, the company added.
The stock was on track for its second consecutive session of gains.
Up to Thursday's close, the stock had fallen 12.45 per cent so far this year.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.